Effector triggered manipulation of host immune response elicited by different pathotypes of escherichia coli

Virulence

Volumn 5, Issue 7, 2014, Pages 733-739

  Jayamani, Elamparithi ^a   Mylonakis, Eleftherios ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

AIEC; Effectors; EHEC; EPEC; IBD; Immunity; Pathogenic E. coli; Type secretion system; Virulence

Indexed keywords

ALPHA CATENIN; BACTERIAL TOXIN; COAT PROTEIN COMPLEX II; CYTOTOXIC NECROTIZING FACTOR 1; HEMOLYSIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN SH3; RAC2 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; VIRULENCE FACTOR; WISKOTT ALDRICH SYNDROME PROTEIN; ESCHERICHIA COLI PROTEIN;

APOPTOSIS; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; CAENORHABDITIS ELEGANS; DIARRHEA; DOWN REGULATION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; GENE SEQUENCE; IMMUNE RESPONSE; INTESTINE FLORA; NONHUMAN; PATHOTYPE; PROTEIN EXPRESSION; PROTEIN MICROARRAY; REVIEW; SIGNAL TRANSDUCTION; UBIQUITINATION; UROPATHOGENIC ESCHERICHIA COLI; ANIMAL; ESCHERICHIA COLI INFECTION; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY;

ANIMALS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; SIGNAL TRANSDUCTION; VIRULENCE FACTORS;

EID: 84908240520     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.29948     Document Type: Review

References (89)

1. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007; 449:819-26; PMID:17943118; http://dx.doi.org/10.1038/nature06246
2. Stuart LM, Paquette N, Boyer L. Effector-triggered versus pattern-triggered immunity: how animals sense pathogens. Nat Rev Immunol 2013; 13:199-206; PMID:23411798; http://dx.doi.org/10.1038/nri3398
3. Blander JM, Sander LE. Beyond pattern recognition: five immune checkpoints for scaling the microbial threat. Nat Rev Immunol 2012; 12:215-25; PMID:22362354; http://dx.doi.org/10.1038/nri3167
4. McEwan DL, Kirienko NV, Ausubel FM. Host translational inhibition by Pseudomonas aeruginosa Exotoxin A Triggers an immune response in Caenorhabditis elegans. Cell Host Microbe 2012; 11:364-74; PMID:22520464; http://dx.doi.org/10.1016/j.chom.2012.02.007
5. Kleino A, Silverman N. UnZIPping mechanisms of effector-triggered immunity in animals. Cell Host Microbe 2012; 11:320-2; PMID:22520459; http://dx.doi.org/10.1016/j.chom.2012.04.002
6. Melo JA, Ruvkun G. Inactivation of conserved C. elegans genes engages pathogen-and xenobiotic-associated defenses. Cell 2012; 149:452-66; PMID:22500807; http://dx.doi.org/10.1016/j. cell.2012.02.050
7. Dunbar TL, Yan Z, Balla KM, Smelkinson MG, Troemel ER. C. elegans detects pathogen-induced translational inhibition to activate immune signaling. Cell Host Microbe 2012; 11:375-86; PMID:22520465; http://dx.doi.org/10.1016/j. chom.2012.02.008
8. Jones JDG, Dangl JL. The plant immune system. Nature 2006; 444:323-9; PMID:17108957; http://dx.doi.org/10.1038/nature05286
9. Boyer L, Magoc L, Dejardin S, Cappillino M, Paquette N, Hinault C, Charriere GM, Ip WK, Fracchia S, Hennessy E, et al. Pathogen-derived effectors trigger protective immunity via activation of the Rac2 enzyme and the IMD or Rip kinase signaling pathway. Immunity 2011; 35:536-49; PMID:22018470; http://dx.doi.org/10.1016/j.immuni.2011.08.015
10. Li B, Yang R. Interaction between Yersinia pestis and the host immune system. Infect Immun 2008; 76:1804-11; PMID:18250178; http://dx.doi.org/10.1128/IAI.01517-07
11. Yao T, Mecsas J, Healy JI, Falkow S, Chien Y. Suppression of T and B lymphocyte activation by a Yersinia pseudotuberculosis virulence factor, yopH. J Exp Med 1999; 190:1343-50; PMID:10544205; http://dx.doi.org/10.1084/jem.190.9.1343
12. Alonso A, Bottini N, Bruckner S, Rahmouni S, Williams S, Schoenberger SP, Mustelin T. Lck dephosphorylation at Tyr-394 and inhibition of T cell antigen receptor signaling by Yersinia phosphatase YopH. J Biol Chem 2004; 279:4922-8; PMID:14623872; http://dx.doi.org/10.1074/jbc. M308978200
13. Kim Y, Mylonakis E. Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system. Eukaryot Cell 2011; 10:782-90; PMID:21498643; http://dx.doi.org/10.1128/EC.00014-11
14. Trivedi P, Wang N. Host immune responses accelerate pathogen evolution. ISME J 2014; 8:727-31; PMID:24304673; http://dx.doi.org/10.1038/ismej.2013.215
15. Spoel SH, Dong X. How do plants achieve immunity? Defence without specialized immune cells. Nat Rev Immunol 2012; 12:89-100; PMID:22273771; http://dx.doi.org/10.1038/nri3141
16. Anderson DM, Frank DW. Five mechanisms of manipulation by bacterial effectors: a ubiquitous theme. PLoS Pathog 2012; 8:e1002823; PMID:22927812; http://dx.doi.org/10.1371/journal. ppat.1002823
17. Shames SR, Finlay BB. Bacterial effector interplay: a new way to view effector function. Trends Microbiol 2012; 20:214-9; PMID:22425230; http://dx.doi.org/10.1016/j.tim.2012.02.007
18. Cambronne ED, Roy CR. Recognition and delivery of effector proteins into eukaryotic cells by bacterial secretion systems. Traffic 2006; 7:929-39; PMID:16734660; http://dx.doi.org/10.1111/j.1600-0854.2006.00446.x
19. Houben ENG, Korotkov KV, Bitter W. Take five-Type VII secretion systems of Mycobacteria. Biochim Biophys Acta 2014;1843:1707-16; PMID:24263244
20. Desvaux M, Hébraud M, Talon R, Henderson IR. Secretion and subcellular localizations of bacterial proteins: a semantic awareness issue. Trends Microbiol 2009; 17:139-45; PMID:19299134; http://dx.doi.org/10.1016/j.tim.2009.01.004
21. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2:123-40; PMID:15040260; http://dx.doi.org/10.1038/nrmicro818
22. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998; 11:142-201; PMID:9457432
23. Croxen MA, Finlay BB. Molecular mechanisms of Escherichia coli pathogenicity. Nature Publishing Group 2009
24. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013; 26:822-80; PMID:24092857; http://dx.doi.org/10.1128/CMR.00022-13
25. Chassaing B, Darfeuille-Michaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140:1720-8; PMID:21530738; http://dx.doi.org/10.1053/j.gastro.2011.01.054
26. Nguyen Y, Sperandio V. Enterohemorrhagic E. coli (EHEC) pathogenesis. Front Cell Infect Microbiol 2012; 2:90-0; PMID:22919681; http://dx.doi.org/10.3389/fcimb.2012.00090
27. Dean P, Kenny B. The effector repertoire of enteropathogenic E. coli: ganging up on the host cell. Curr Opin Microbiol 2009; 12:101-9; PMID:19144561; http://dx.doi.org/10.1016/j.mib.2008.11.006
28. Navarro-Garcia F, Serapio-Palacios A, Ugalde-Silva P, Tapia-Pastrana G, Chavez-Dueñas L. Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes. Biomed Res Int 2013; 2013:374395; PMID:23509714; http://dx.doi.org/10.1155/2013/374395
29. Vidal JE, Navarro-García F. EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems. Cell Microbiol 2008; 10:1975-86; PMID:18547338; http://dx.doi.org/10.1111/j.1462-5822.2008.01181.x
30. Chassaing B, Koren O, Carvalho FA, Ley RE, Gewirtz AT. AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut 2014;63:1069-80; PMID:23896971
31. Carvalho FA, Barnich N, Sivignon A, Darcha C, Chan CHF, Stanners CP, Darfeuille-Michaud A. Crohn’s disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med 2009; 206:2179-89; PMID:19737864; http://dx.doi.org/10.1084/jem.20090741
32. Lapaquette P, Glasser A-L, Huett A, Xavier RJ, Darfeuille-Michaud A. Crohn’s disease-associated adherent-invasive E. coli are selectively favoured by impaired autophagy to replicate intracellularly. Cell Microbiol 2010; 12:99-113; PMID:19747213; http://dx.doi.org/10.1111/j.1462-5822.2009.01381.x
33. Bringer M-A, Glasser A-L, Tung C-H, Méresse S, Darfeuille-Michaud A. The Crohn’s diseaseassociated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages. Cell Microbiol 2006; 8:471-84; PMID:16469058; http://dx.doi.org/10.1111/j.1462-5822.2005.00639.x
34. Nash JH, Villegas A, Kropinski AM, Aguilar-Valenzuela R, Konczy P, Mascarenhas M, Ziebell K, Torres AG, Karmali MA, Coombes BK. Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes. BMC Genomics 2010; 11:667; PMID:21108814; http://dx.doi.org/10.1186/1471-2164-11-667
35. Strober W. Adherent-invasive E. coli in Crohn disease: bacterial “agent provocateur”. J Clin Invest 2011; 121:841-4; PMID:21339637; http://dx.doi.org/10.1172/JCI46333
36. Ho BT, Dong TG, Mekalanos JJ. A view to a kill: the bacterial type VI secretion system. Cell Host Microbe 2014; 15:9-21; PMID:24332978; http://dx.doi.org/10.1016/j.chom.2013.11.008
37. Davis JM, Rasmussen SB, O’Brien AD. Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect Immun 2005; 73:5301-10; PMID:16113245; http://dx.doi.org/10.1128/IAI.73.9.5301-5310.2005
38. Krachler AM, Woolery AR, Orth K. Manipulation of kinase signaling by bacterial pathogens. J Cell Biol 2011; 195:1083-92; PMID:22123833; http://dx.doi.org/10.1083/jcb.201107132
39. Lamkanfi M, Dixit VM. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe 2010; 8:44-54; PMID:20638641; http://dx.doi.org/10.1016/j.chom.2010.06.007
40. Ham H, Sreelatha A, Orth K. Manipulation of host membranes by bacterial effectors. Nat Rev Microbiol 2011; 9:635-46; PMID:21765451; http://dx.doi.org/10.1038/nrmicro2602
41. Lee HK, Iwasaki A. Innate control of adaptive immunity: dendritic cells and beyond. Semin Immunol 2007; 19:48-55; PMID:17276695; http://dx.doi.org/10.1016/j.smim.2006.12.001
42. Garmendia J, Frankel G, Crepin VF. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 2005; 73:2573-85; PMID:15845459; http://dx.doi.org/10.1128/IAI.73.5.2573-2585.2005
43. Gruenheid S, DeVinney R, Bladt F, Goosney D, Gelkop S, Gish GD, Pawson T, Finlay BB. Enteropathogenic E. coli Tir binds Nck to initiate actin pedestal formation in host cells. Nat Cell Biol 2001; 3:856-9; PMID:11533668; http://dx.doi.org/10.1038/ncb0901-856
44. Kurisu S, Takenawa T. The WASP and WAVE family proteins. Genome Biol 2009; 10:226; PMID:19589182; http://dx.doi.org/10.1186/gb-2009-10-6-226
45. Takenawa T, Suetsugu S. The WASP-WAVE protein network: connecting the membrane to the cytoskeleton. Nat Rev Mol Cell Biol 2007; 8:37-48; PMID:17183359; http://dx.doi.org/10.1038/nrm2069
46. Rajmohan R, Wong MH, Meng L, Munn AL, Thanabalu T. Las17p-Vrp1p but not Las17p-Arp2/3 interaction is important for actin patch polarization in yeast. Biochim Biophys Acta 2009; 1793:825-35; PMID:19272406; http://dx.doi.org/10.1016/j. bbamcr.2009.02.012
47. Rajmohan R, Raodah A, Wong MH, Thanabalu T. Characterization of Wiskott-Aldrich syndrome (WAS) mutants using Saccharomyces cerevisiae. FEMS Yeast Res 2009; 9:1226-35; PMID:19817875; http://dx.doi.org/10.1111/j.1567-1364.2009.00581.x
48. Nolen BJ, Littlefield RS, Pollard TD. Crystal structures of actin-related protein 2/3 complex with bound ATP or ADP. Proc Natl Acad Sci U S A 2004; 101:15627-32; PMID:15505213; http://dx.doi.org/10.1073/pnas.0407149101
49. Wong MH, Meng L, Rajmohan R, Yu S, Thanabalu T. Vrp1p-Las17p interaction is critical for actin patch polarization but is not essential for growth or fluid phase endocytosis in S. cerevisiae. Biochim Biophys Acta 2010; 1803:1332-46; PMID:20816901; http://dx.doi.org/10.1016/j.bbamcr.2010.08.013
50. Tu X, Nisan I, Yona C, Hanski E, Rosenshine I. EspH, a new cytoskeleton-modulating effector of enterohaemorrhagic and enteropathogenic Escherichia coli. Mol Microbiol 2003; 47:595-606; PMID:12535063; http://dx.doi.org/10.1046/j.1365-2958.2003.03329.x
51. Misra A, George B, Rajmohan R, Jain N, Wong MH, Kambadur R, Thanabalu T. Insulin receptor substrate protein 53kDa (IRSp53) is a negative regulator of myogenic differentiation. Int J Biochem Cell Biol 2012; 44:928-41; PMID:22465711; http://dx.doi.org/10.1016/j.biocel.2012.02.020
52. Misra A, Rajmohan R, Lim RPZ, Bhattacharyya S, Thanabalu T. The mammalian verprolin, WIRE induces filopodia independent of N-WASP through IRSp53. Exp Cell Res 2010; 316:2810-24; PMID:20678498; http://dx.doi.org/10.1016/j. yexcr.2010.07.015
53. Wong ARC, Raymond B, Collins JW, Crepin VF, Frankel G. The enteropathogenic E. coli effector EspH promotes actin pedestal formation and elongation via WASP-interacting protein (WIP). Cell Microbiol 2012; 14:1051-70; PMID:22372637; http://dx.doi.org/10.1111/j.1462-5822.2012.01778.x
54. Iizumi Y, Sagara H, Kabe Y, Azuma M, Kume K, Ogawa M, Nagai T, Gillespie PG, Sasakawa C, Handa H. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function. Cell Host Microbe 2007; 2:383-92; PMID:18078690; http://dx.doi.org/10.1016/j.chom.2007.09.012
55. Chiu H-J, Syu W-J. Functional analysis of EspB from enterohaemorrhagic Escherichia coli. Microbiology 2005; 151:3277-86; PMID:16207911; http://dx.doi.org/10.1099/mic.0.28115-0
56. Taylor KA, Luther PW, Donnenberg MS. Expression of the EspB protein of enteropathogenic Escherichia coli within HeLa cells affects stress fibers and cellular morphology. Infect Immun 1999; 67:120-5; PMID:9864205
57. Kodama T, Akeda Y, Kono G, Takahashi A, Imura K, Iida T, Honda T. The EspB protein of enterohaemorrhagic Escherichia coli interacts directly with alpha-catenin. Cell Microbiol 2002; 4:213-22; PMID:11952638; http://dx.doi.org/10.1046/j.1462-5822.2002.00176.x
58. Selyunin AS, Alto NM. Activation of PAK by a bacterial type III effector EspG reveals alternative mechanisms of GTPase pathway regulation. Small GTPases 2011; 2:217-21; PMID:22145094; http://dx.doi.org/10.4161/sgtp.2.4.16704
59. Clements A, Smollett K, Lee SF, Hartland EL, Lowe M, Frankel G. EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function. Cell Microbiol 2011; 13:1429-39; PMID:21740499; http://dx.doi.org/10.1111/j.1462-5822.2011.01631.x
60. Germane KL, Spiller BW. Structural and functional studies indicate that the EPEC effector, EspG, directly binds p21-activated kinase. Biochemistry 2011; 50:917-9; PMID:21235237; http://dx.doi.org/10.1021/bi1020138
61. de Curtis I. Host-pathogen interactions: cheating the host by making new connections. Curr Biol 2011; 21:R192-4; PMID:21377097; http://dx.doi.org/10.1016/j.cub.2011.01.041
62. Kim J, Thanabalasuriar A, Chaworth-Musters T, Fromme JC, Frey EA, Lario PI, Metalnikov P, Rizg K, Thomas NA, Lee SF, et al. The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function. Cell Host Microbe 2007; 2:160-71; PMID:18005731; http://dx.doi.org/10.1016/j.chom.2007.07.010
63. Thanabalasuriar A, Koutsouris A, Hecht G, Gruenheid S. The bacterial virulence factor NleA’s involvement in intestinal tight junction disruption during enteropathogenic E. coli infection is independent of its putative PDZ binding domain. Gut Microbes 2010; 1:114-8; PMID:21326920; http://dx.doi.org/10.4161/gmic.1.2.11685
64. Dennis A, Kudo T, Kruidenier L, Girard F, Crepin VF, MacDonald TT, Frankel G, Wiles S. The p50 subunit of NF-kappaB is critical for in vivo clearance of the noninvasive enteric pathogen Citrobacter rodentium. Infect Immun 2008; 76:4978-88; PMID:18694964; http://dx.doi.org/10.1128/IAI.00736-08
65. Royan SV, Jones RM, Koutsouris A, Roxas JL, Falzari K, Weflen AW, Kim A, Bellmeyer A, Turner JR, Neish AS, et al. Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation. Mol Microbiol 2010; 78:1232-45; PMID:21091507; http://dx.doi.org/10.1111/j.1365-2958.2010.07400.x
66. Pham TH, Gao X, Tsai K, Olsen R, Wan F, Hardwidge PR. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2. Infect Immun 2012; 80:2133-40; PMID:22451523; http://dx.doi.org/10.1128/IAI.06358-11
67. Hemrajani C, Berger CN, Robinson KS, Marchès O, Mousnier A, Frankel G. NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection. Proc Natl Acad Sci U S A 2010; 107:3129-34; PMID:20133763; http://dx.doi.org/10.1073/pnas.0911609106
68. Ashida H, Mimuro H, Ogawa M, Kobayashi T, Sanada T, Kim M, Sasakawa C. Cell death and infection: a double-edged sword for host and pathogen survival. J Cell Biol 2011; 195:931-42; PMID:22123830; http://dx.doi.org/10.1083/jcb.201108081
69. Pearson JS, Giogha C, Ong SY, Kennedy CL, Kelly M, Robinson KS, Lung TWF, Mansell A, Riedmaier P, Oates CVL, et al. A type III effector antagonizes death receptor signalling during bacterial gut infection. Nature 2013; 501:247-51; PMID:24025841; http://dx.doi.org/10.1038/nature12524
70. Gao X, Wang X, Pham TH, Feuerbacher LA, Lubos M-L, Huang M, Olsen R, Mushegian A, Slawson C, Hardwidge PR. NleB, a bacterial effector with glycosyltransferase activity, targets GAPDH function to inhibit NF-κB activation. Cell Host Microbe 2013; 13:87-99; PMID:23332158; http://dx.doi.org/10.1016/j.chom.2012.11.010
71. Li S, Zhang L, Yao Q, Li L, Dong N, Rong J, Gao W, Ding X, Sun L, Chen X, et al. Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains. Nature 2013; 501:242-6; PMID:23955153; http://dx.doi.org/10.1038/nature12436
72. Yen H, Ooka T, Iguchi A, Hayashi T, Sugimoto N, Tobe T. NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA. PLoS Pathog 2010; 6:e1001231; PMID:21187904; http://dx.doi.org/10.1371/journal.ppat.1001231
73. Sham HP, Shames SR, Croxen MA, Ma C, Chan JM, Khan MA, Wickham ME, Deng W, Finlay BB, Vallance BA. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation. Infect Immun 2011; 79:3552-62; PMID:21746856; http://dx.doi.org/10.1128/IAI.05033-11
74. Baruch K, Gur-Arie L, Nadler C, Koby S, Yerushalmi G, Ben-Neriah Y, Yogev O, Shaulian E, Guttman C, Zarivach R, et al. Metalloprotease type III effectors that specifically cleave JNK and NF-κB. EMBO J 2011; 30:221-31; PMID:21113130; http://dx.doi.org/10.1038/emboj.2010.297
75. Wu B, Skarina T, Yee A, Jobin M-C, Dileo R, Semesi A, Fares C, Lemak A, Coombes BK, Arrowsmith CH, et al. NleG Type 3 effectors from enterohaemorrhagic Escherichia coli are U-Box E3 ubiquitin ligases. PLoS Pathog 2010; 6:e1000960; PMID:20585566; http://dx.doi.org/10.1371/journal.ppat.1000960
76. Zinngrebe J, Montinaro A, Peltzer N, Walczak H. Ubiquitin in the immune system. EMBO Rep 2014; 15:28-45; PMID:24375678; http://dx.doi.org/10.1002/embr.201338025
77. Angot A, Vergunst A, Genin S, Peeters N. Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog 2007; 3:e3; PMID:17257058; http://dx.doi.org/10.1371/journal.ppat.0030003
78. Pfanner N, Meijer M. The Tom and Tim machine. Curr Biol 1997; 7:R100-3; PMID:9081657; http://dx.doi.org/10.1016/S0960-9822(06)00048-0
79. Chacinska A, van der Laan M, Mehnert CS, Guiard B, Mick DU, Hutu DP, Truscott KN, Wiedemann N, Meisinger C, Pfanner N, et al. Distinct forms of mitochondrial TOM-TIM supercomplexes define signal-dependent states of preprotein sorting. Mol Cell Biol 2010; 30:307-18; PMID:19884344; http://dx.doi.org/10.1128/MCB.00749-09
80. Kozjak-Pavlovic V, Ross K, Rudel T. Import of bacterial pathogenicity factors into mitochondria. Curr Opin Microbiol 2008; 11:9-14; PMID:18280201; http://dx.doi.org/10.1016/j.mib.2007.12.004
81. Kozjak-Pavlovic V, Dian-Lothrop EA, Meinecke M, Kepp O, Ross K, Rajalingam K, Harsman A, Hauf E, Brinkmann V, Günther D, et al. Bacterial porin disrupts mitochondrial membrane potential and sensitizes host cells to apoptosis. PLoS Pathog 2009; 5:e1000629; PMID:19851451; http://dx.doi.org/10.1371/journal.ppat.1000629
82. Liu Y, Samuel BS, Breen PC, Ruvkun G. Caenorhabditis elegans pathways that surveil and defend mitochondria. Nature 2014; 508:406-10; PMID:24695221; http://dx.doi.org/10.1038/nature13204
83. Marchès O, Batchelor M, Shaw RK, Patel A, Cummings N, Nagai T, Sasakawa C, Carlsson SR, Lundmark R, Cougoule C, et al. EspF of enteropathogenic Escherichia coli binds sorting nexin 9. J Bacteriol 2006; 188:3110-5; PMID:16585770; http://dx.doi.org/10.1128/JB.188.8.3110-3115.2006
84. Nougayrède J-P, Foster GH, Donnenberg MS. Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2. Cell Microbiol 2007; 9:680-93; PMID:17064289; http://dx.doi.org/10.1111/j.1462-5822.2006.00820.x
85. Rajamuthiah R, Fuchs BB, Jayamani E, Kim Y, Larkins-Ford J, Conery A, Ausubel FM, Mylonakis E. Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureus. PLoS One 2014; 9:e89189; PMID:24586584; http://dx.doi.org/10.1371/journal.pone.0089189
86. Shames SR, Croxen MA, Deng W, Finlay BB. The type III system-secreted effector EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial membrane 17b. Infect Immun 2011; 79:4784-90; PMID:21947777; http://dx.doi.org/10.1128/IAI.05761-11
87. Shames SR, Finlay BB. Breaking the stereotype: virulence factor-mediated protection of host cells in bacterial pathogenesis. PLoS Pathog 2010; 6:e1001057; PMID:20862318; http://dx.doi.org/10.1371/journal. ppat.1001057
88. Berger CN, Crepin VF, Baruch K, Mousnier A, Rosenshine I, Frankel G. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation. MBio 2012; 3:3; PMID:23033475; http://dx.doi.org/10.1128/mBio.00317-12
89. Jepson MA, Pellegrin S, Peto L, Banbury DN, Leard AD, Mellor H, Kenny B. Synergistic roles for the Map and Tir effector molecules in mediating uptake of enteropathogenic Escherichia coli (EPEC) into non-phagocytic cells. Cell Microbiol 2003; 5:773-83; PMID:14531893; http://dx.doi.org/10.1046/j.1462-5822.2003.00315.x